Trials / Withdrawn
WithdrawnNCT01557023
Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Eurofarma Laboratorios S.A. · Industry
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
This trial will study the percentage of women with at least one occurrence of intracyclic bleeding (bleeding and/or spotting) during the cycles 2 and 3 of treatment with test or reference drug.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | barrier methods | |
| DRUG | barrier methods |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2012-03-19
- Last updated
- 2017-09-21
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01557023. Inclusion in this directory is not an endorsement.